- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06063564
Adapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care Clinics
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63130
- Recruiting
- Washington University in St. Louis
-
Contact:
- Maura M Kepper, PhD
- Phone Number: 3149350142
- Email: kepperm@wustl.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18-64 years at baseline
- a BMI ≥ 30
- Receiving care from the Missouri Highlands.
- Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Wait-List Control
Complete questionnaires at baseline (administered electronically or by mail).
Follow-up measures will be administered immediately following their clinic visit and at 6-months after the clinic visit electronically and by mail.
A PREVENT action plan (behavior change prescription, community resources, and education) will be provided to the patient via email after the completion of the follow-up measurement.
|
Will receive routine clinical care.
After completion of follow-up measures, control participants will receive a behavior change prescription via the PREVENT tool.
|
|
Experimental: PREVENT Intervention
Complete questionnaires at baseline (administered electronically or by mail). Follow-up measures will be administered immediately following the clinic visit, and monthly for 6-months after the clinic visit electronically and by mail At the clinic visit, the provider will use the PREVENT tool to discuss CVH risk. A community health worker (CHW) will deliver a tailored behavioral change plan inclusive of patient-centered community resources. The CHW will provide ongoing support with goals and social needs for 6-months. |
PREVENT is a novel Health Information Technology tool designed to promote physical activity and healthy food intake among overweight/obese patients at the point of care.
PREVENT automates the delivery of personalized, evidence-based behavior change recommendations and provides an interactive map of community resources to help providers link patients to resources in their community.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' satisfaction of PREVENT tool: survey
Time Frame: 6-months
|
A survey (6-questions) will assess patient's satisfaction with the PREVENT tool.
Questions are asked on a 5-point Likert scale (range: 6-30) with a higher score indicating greater satisfaction.
|
6-months
|
|
Provider's satisfaction of PREVENT tool: survey
Time Frame: Up to 12 weeks post-study
|
A survey (31-questions) will assess provider's acceptability and satisfaction with five aspects of health information technology: content, accuracy, format, ease of use and timeliness.
Questions are asked on a 5-point Likert scale (range: 31-155) with a higher score indicating greater satisfaction.
|
Up to 12 weeks post-study
|
|
Fidelity of PREVENT tool implementation
Time Frame: 0-6 months
|
Fidelity will be measured using direct observation of patient-provider interactions while using the PREVENT tool.
A direct observation checklist will be used by the observer to determine the number of interactions with the PREVENT tool that were implemented as intended.
|
0-6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in provider confidence: survey
Time Frame: At baseline, and 6-months
|
Provider confidence in discussing CVH and health behaviors with overweight and obese patients will be assessed using a survey (4-questions).
Questions are asked on 5-point Likert scale (range: 4-20) with a higher score indicating greater confidence.
|
At baseline, and 6-months
|
|
Quality of health behavior counseling
Time Frame: Immediately following clinic visit
|
Patient perceptions of the clinical interaction in which CVH and health behaviors will be assessed using a survey (10- questions).
Questions are asked as yes/no/I don't' know.
Quality counseling will be defined as patient reported yes to their care team: 1) talking to them about healthy food intake; 2) talking to them about physical activity 3) delivering goals and 4) delivering resources.
|
Immediately following clinic visit
|
|
Change in body mass index (BMI)
Time Frame: At baseline, and 6-months
|
Collected from patient's medical record.
|
At baseline, and 6-months
|
|
Change on patient's average systolic and diastolic blood pressure
Time Frame: At baseline, and 6-months
|
Collected from patient's medical record.
|
At baseline, and 6-months
|
|
Change in patient's cholesterol
Time Frame: At baseline, and 6-months
|
Collected from patient's medical record.
|
At baseline, and 6-months
|
|
Change in patient's blood glucose
Time Frame: At baseline, and 6-months
|
Collected from patient's medical record.
|
At baseline, and 6-months
|
|
Change in patient's motivation
Time Frame: At baseline, 3 months and 6-months
|
A survey (15-question) administered to patients will assess motivation and self-efficacy for behavior change.
Questions are asked using a 5-point Likert scale (range: 15-75) with a higher score indicating greater motivation.
|
At baseline, 3 months and 6-months
|
|
Change in food intake behaviors
Time Frame: At baseline, 3 months and 6-months
|
Patient-reported food intake behaviors (fruit and vegetable intake, whole grains, sugar-sweetened beverages and snacking behaviors) are collected using a brief Health Behavior & Attitudes Survey.
|
At baseline, 3 months and 6-months
|
|
Change in minutes of moderate to vigorous physical activity
Time Frame: At baseline, 3 months and 6-months
|
Patient-reported physical activity (minutes of moderate and vigorous activity per week) are collected using a survey (4-questions).
Patients report the average number of minutes of moderate and vigorous activity they do per week.
|
At baseline, 3 months and 6-months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202307156
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
National Medical Research Center for Therapy and...BU "Respublikanski Kardiologicheski Dispanser" Minzdrava Chuvashii, CheboksaryCompletedMultimorbidity, Cardiovascular DiseasesRussian Federation
Clinical Trials on Wait-list Control
-
New York State Psychiatric InstituteCompletedCognitive Deterioration | Disorder of AgingUnited States
-
University of OsloNorwegian Institute of Public Health; Norwegian Council for Mental Health; The...CompletedQuality of Life | Wellbeing | Health AttitudeNorway
-
New York State Psychiatric InstituteFeinstein Institute for Medical ResearchCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
Kaohsiung Medical University Chung-Ho Memorial...Kaohsiung Medical UniversityUnknownHead and Neck CancerTaiwan
-
Macmillan Research Group UKNMP Medical Research Institute; Warwick Research ServicesUnknownRheumatic ArthritisIndia
-
VA Office of Research and DevelopmentCompletedSuicide | Mental HealthUnited States
-
Seattle Children's HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Gynecologic Cancer | Peripheral NeuropathyUnited States
-
University Health Network, TorontoUniversity of British Columbia; University of Toronto; Dalhousie University; Canadian... and other collaboratorsCompleted